e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Exercise intolerance: mechanism, intervention and assessment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The index distance-saturation product like predicting of mortality in patients with COPD
S. Pecho (Lima, Peru)
Source:
Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Session:
Exercise intolerance: mechanism, intervention and assessment
Session type:
E-Communication Session
Number:
425
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pecho (Lima, Peru). The index distance-saturation product like predicting of mortality in patients with COPD. Eur Respir J 2008; 32: Suppl. 52, 425
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Validation of bode index as a predictor of mortality in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
A longitudinal study of the relationship between serial changes in BODE index, mortality and readmissions in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
CURB-65 scoring utilization in predicting mortality of hospitalized patients with AE-COPD
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Could age-adjusted Charlson comorbidity index predict outcomes in patients submitted to noninvasive ventilation?
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017
FEV
1
/Height
2
could be a better alternative than FEV
1
in predicting all cause mortality in patients with COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Higher BODE Index in COPD patients correlated with higher number of comorbidities
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
A simplified BODE score to predict mortality in patients with COPD: the role of 4-min step test
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis
Source: ERJ Open Res, 4 (1) 00139-2017; 10.1183/23120541.00139-2017
Year: 2018
Karnofsky index as predictor of exacerbations in moderate and severe COPD patients
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
The value of short physical performance battery (SPPB) as an alternative component of the BODE Index in predicting death in chronic obstructive pulmonary disease (COPD) in the ERICA cohort.
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
Can we assess COPD comorbidities by BODE index?
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
CURB65 versus PSI in assessing the severity of CAP of elderly patients
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept